Le Lézard
Classified in: Health
Subjects: SBS, MAT

ACS Laboratory Expands Testing Scope and Introduces Amanita Mushroom Testing Panels for Product Safety and Compliance


BOCA RATON, Fla., Aug. 16, 2023 /PRNewswire/ -- ACS Laboratory, the largest hemp and cannabis testing facility in the Eastern U.S., launched a comprehensive Amanita mushroom testing program. Its analytical panels cater to the burgeoning Amanita industry, providing accurate and reliable results for potency, purity and compliance. ACS Laboratory's cutting-edge program allows innovative brands to offer the highest quality products while adhering to safety and legal standards.

As Amanita mushrooms gain popularity for their unique psychoactive effects and unregulated ingredients, ACS Laboratory believes it's crucial to accurately quantify their strength, purity and more importantly the absence of psilocybin, psilocin and contaminants that a DEA-licensed lab can provide. The facility's testing capabilities include Amanita muscaria and Amanita pantherina species, enabling clients to obtain Certificates of Analysis (COAs) with documented results.

In 2023, ACS Laboratory expanded its testing scope from cannabis and hemp to mushrooms and Kratom. Having a DEA license enables ACS Laboratory to test psilocybin containing mushrooms as well as Amanita products for compliance. As a DEA-licensed laboratory, compliance in ruling out potentially illicit compounds such as Psilocybin and Psilocin is incredibly important.

ACS Laboratory tests Amanita mushrooms in various product types, including dried mushrooms, powders, chocolates, tinctures, gummies and capsules. The team also conducts ongoing research to better understand Amanita's active ingredients and potential medicinal applications. With a strong commitment to precision and reliability, ACS Laboratory is a trusted partner for transparent brands that seek to produce exceptional products.

"We understand the importance of delivering precise results to our clients in the Amanita mushroom industry," said Roger Brown, president at ACS Laboratory. "Our state-of-the-art facility and advanced methodologies enable us to deliver accurate and clinical-grade results, reinforcing our commitment to excellence and accountability."

To enhance transparency and accessibility, ACS Laboratory generates a Certificate of Analysis (COA) for each sample, available through a public portal. Additionally, the laboratory provides QR codes linked to the COA for product packaging and utilizes blockchain technology for secure tracking and tamper-proofing. These measures build consumer trust and prevent fraud.

For more information about ACS Laboratory's mushroom testing, visit https://www.acslab.com/services/mushroom-testing.

About ACS Laboratory:
ACS Laboratory is an award-winning testing facility serving the cannabis, hemp, mushroom and kratom industries with consistent, precise results. The team has earned 82 Emerald Test Badges for accurate results, more than any other lab in the USA. Exceeding regulatory requirements, ACS is ISO/IEC 17025:2017 accredited, DEA licensed, CLIA licensed and hemp-testing compliant in all 50 states (including Puerto Rico), and 17 countries. The facility is also a Florida Department of Health "Certified Marijuana Testing Laboratory." Beyond compliance, ACS is committed to innovation, continuously developing protocols to support clients as they expand into new product types and verticals. ACS Laboratory operates a 20,000 sq. ft. facility, making it the largest in the Eastern USA. Explore ACS' blog for the latest botanical science and laboratory testing information. Visit www.acslab.com for a complete list of testing services and capabilities.

Media Contact:
Durée & Company, Inc.
954-723-9350 /  [email protected]

SOURCE ACS Laboratory


These press releases may also interest you

at 08:15
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced positive...

at 08:13
Green Security LLC, a leading provider of SaaS healthcare compliance and access management solutions, today announced that Anna Ormiston joins the team as the Vice President of Customer Success & Operations. Ormiston brings over two decades of...

at 08:10
Alzamend Neuro, Inc. ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and...

at 08:10
Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, announced it will present new clinical data on two innovative platforms, the DynamX Coronary Bioadaptor System and LithiX Hertz Contact Intravascular Lithotripsy...

at 08:10
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, today announced preclinical and clinical data releases for the afabicin...

at 08:10
MDVIP, the market leader in membership-based healthcare with a network of over 1,300 primary care physicians nationwide, today announced the opening of two new MDVIP-affiliated practices in North Carolina. Lori D. Peele, MD, a board-certified family...



News published on and distributed by: